Iron-deficiency Anemia Clinical Trial
Official title:
EHR-based Patient Identification and Panel Management of Patients With Iron Deficiency Anemia, a Pragmatic Primary Care Physician Randomized Trial of a Quality Improvement Method
Verified date | February 2023 |
Source | Northwestern University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The objective is to determine if a set of clinical supports that includes computer-assisted identification, an EHR registry, facilitated GI referral, and an EHR tool for documentation improves the timely referral and completion of bidirectional endoscopy in men aged 18 years and older and women aged 40 years and older with iron deficiency anemia.
Status | Completed |
Enrollment | 16 |
Est. completion date | January 11, 2023 |
Est. primary completion date | June 28, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 21 Years and older |
Eligibility | Inclusion Criteria: Northwestern Medical Group primary care physician (internal medicine, family medicine or geriatrics) Exclusion Criteria: No primary care office practice within Northwestern Medical Group |
Country | Name | City | State |
---|---|---|---|
United States | Northwestern University, Division of General Internal Medicine | Chicago | Illinois |
United States | Stephen D Persell | Chicago | Illinois |
Lead Sponsor | Collaborator |
---|---|
Northwestern University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Bidirectional endoscopy completed | Completion of upper and lower endoscopy, assessed using automated queries of the Northwestern Medicine Enterprise Data Warehouse occurring within the three years prior to the study start date and the 120 days following the study start date.
Specificially, presence of one or more terms for a completed procedure from the code set for Espohagoduodenoscopy/Upper Endoscopy and one or more terms from the code set for Colonoscopy within the indicated time frame constitutes completion of the measure. Note:the investigators use a three-year look back because eligible patients may have completed either upper or lower endoscopy previously and only require one form of endoscopy during the study period. |
120 days | |
Secondary | Endoscopy completed or scheduled | Discrete evidence in the EHR that endoscopy has been completed or scheduled on or after the study start date.
Specificially, presence in the Northwestern Medicine EHR of a completed or future scheduled procedure for one or more terms from the code set for Espohagoduodenoscopy/Upper Endoscopy or one or more terms from the code set for Colonoscopy within the indicated time frame constitutes completion of the measure. Note:the investigators use a three-year look back because eligible patients may have completed either upper or lower endoscopy previously and only require one form of endoscopy during the study period. |
120 days | |
Secondary | Gastroenterology consultation completed | Completion of a consultation with gastroenterology (in person or telehealth) on or after the study start date
Specificially, this outcome is indicated by the presence in the Northwestern Medicine EHR of a completed office visit or telehealth visit with a physician, physician assistant or advance practice nurse in the within the specialty department of gastroenterology. |
120 days | |
Secondary | GI referral provided or completed | Receipt of a referral to gastroenterology or completion of a consultation with gastroenterology
Specificially, this outcome is indicated by the presence in the Northwestern Medicine EHR of a completed office visit or telehealth visit with a physician, physician assistant or advance practice nurse in the within the specialty department of gastroenterology or the presence of a signed order for a gastroenterology referral or an endoscopy referral. |
120 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04949165 -
Bloodsafe Ghana- Iron and Nutritional Counseling Strategy Pilot Study
|
N/A | |
Active, not recruiting |
NCT02541708 -
IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania
|
Phase 3 | |
Completed |
NCT01942460 -
Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis Patients
|
Phase 4 | |
Completed |
NCT01047098 -
Effects of Taking Prenatal Vitamin-mineral Supplements During Lactation on Iron Status and Markers of Oxidation
|
N/A | |
Completed |
NCT00810030 -
FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR
|
Phase 3 | |
Completed |
NCT00298051 -
Umbilical Cord Clamping and Infant Iron Status
|
N/A | |
Completed |
NCT01135576 -
Iron Fortified Beverages and Application in Women Predisposed to Anemia
|
N/A | |
Withdrawn |
NCT04320966 -
Neurovascular Complications and White Matter Damage in Acquired Anemias
|
||
Completed |
NCT01101399 -
Ferric Carboxymaltose in Subjects With Functional Iron Deficiency Undergoing Chemotherapy
|
Phase 3 | |
Completed |
NCT05240677 -
Endoscopy in CKD With Iron Deficiency Anemia
|
N/A | |
Terminated |
NCT01100879 -
Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving Chemotherapy
|
Phase 4 | |
Recruiting |
NCT02487719 -
Different Iron Supplements for Prevention of Anemia in Pregnancy
|
Phase 4 | |
Recruiting |
NCT03232554 -
Buxue Yimu Pills for Gynecological Iron-Deficiency Anemia
|
Phase 2 | |
Terminated |
NCT02341300 -
Use of Cast Iron Pots to Improve Maternal Anemia
|
N/A | |
Completed |
NCT04318405 -
Real Life Study on Iron Isomaltoside 1000 in the Treatment of ID in CKD, Heart Failure, ObGyn, IBD, Cancer and Elective Surgery (Real-CHOICE).
|
||
Completed |
NCT02998697 -
Short Term Oral Iron Supplementation in Systolic Heart Failure Patients Suffering From Iron Deficiency Anemia
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT03411590 -
The Effect of Fortified Growing-up Milk on Growth and Micronutrient Status of Nigerian Toddlers
|
N/A | |
Recruiting |
NCT01071759 -
Effects of Dietary Heme/Non-heme Iron and Helicobacter Pylori (Hp) Infection on Maternal Iron-deficiency Anemia and Fetal Growth Outcomes
|
N/A | |
Terminated |
NCT00882414 -
Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD)
|
Phase 2 | |
Completed |
NCT02968368 -
Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
|
Phase 3 |